OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Intestinal microbiome and fitness in kidney disease
Björn Meijers, Pieter Evenepoel, Hans‐Joachim Anders
Nature Reviews Nephrology (2019) Vol. 15, Iss. 9, pp. 531-545
Open Access | Times Cited: 162
Björn Meijers, Pieter Evenepoel, Hans‐Joachim Anders
Nature Reviews Nephrology (2019) Vol. 15, Iss. 9, pp. 531-545
Open Access | Times Cited: 162
Showing 1-25 of 162 citing articles:
Acute kidney injury
John A. Kellum, Paola Romagnani, Gloria Ashuntantang, et al.
Nature Reviews Disease Primers (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 973
John A. Kellum, Paola Romagnani, Gloria Ashuntantang, et al.
Nature Reviews Disease Primers (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 973
Aberrant gut microbiota alters host metabolome and impacts renal failure in humans and rodents
Xifan Wang, Songtao Yang, Shenghui Li, et al.
Gut (2020) Vol. 69, Iss. 12, pp. 2131-2142
Open Access | Times Cited: 359
Xifan Wang, Songtao Yang, Shenghui Li, et al.
Gut (2020) Vol. 69, Iss. 12, pp. 2131-2142
Open Access | Times Cited: 359
Role of the gut microbiota in type 2 diabetes and related diseases
Ge Yang, Jinlong Wei, Pinyi Liu, et al.
Metabolism (2021) Vol. 117, pp. 154712-154712
Closed Access | Times Cited: 279
Ge Yang, Jinlong Wei, Pinyi Liu, et al.
Metabolism (2021) Vol. 117, pp. 154712-154712
Closed Access | Times Cited: 279
Gut Microbial Metabolites of Aromatic Amino Acids as Signals in Host–Microbe Interplay
Yali Liu, Yuanlong Hou, Guangji Wang, et al.
Trends in Endocrinology and Metabolism (2020) Vol. 31, Iss. 11, pp. 818-834
Closed Access | Times Cited: 256
Yali Liu, Yuanlong Hou, Guangji Wang, et al.
Trends in Endocrinology and Metabolism (2020) Vol. 31, Iss. 11, pp. 818-834
Closed Access | Times Cited: 256
Food as medicine: targeting the uraemic phenotype in chronic kidney disease
Denise Mafra, Natália Alvarenga Borges, Bengt Lindholm, et al.
Nature Reviews Nephrology (2020) Vol. 17, Iss. 3, pp. 153-171
Closed Access | Times Cited: 177
Denise Mafra, Natália Alvarenga Borges, Bengt Lindholm, et al.
Nature Reviews Nephrology (2020) Vol. 17, Iss. 3, pp. 153-171
Closed Access | Times Cited: 177
Association of metabolic dysfunction-associated fatty liver disease with kidney disease
Ting-Yao Wang, Rui-Fang Wang, Zhi-Ying Bu, et al.
Nature Reviews Nephrology (2022) Vol. 18, Iss. 4, pp. 259-268
Open Access | Times Cited: 140
Ting-Yao Wang, Rui-Fang Wang, Zhi-Ying Bu, et al.
Nature Reviews Nephrology (2022) Vol. 18, Iss. 4, pp. 259-268
Open Access | Times Cited: 140
The Role of the Gut Microbiome in Diabetes and Obesity-Related Kidney Disease
Amgad Zaky, Sarah Glastras, May Wong, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9641-9641
Open Access | Times Cited: 124
Amgad Zaky, Sarah Glastras, May Wong, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9641-9641
Open Access | Times Cited: 124
Targeting innate immunity-driven inflammation in CKD and cardiovascular disease
Thimoteus Speer, Stefanie Dimmeler, Stefan Schunk, et al.
Nature Reviews Nephrology (2022) Vol. 18, Iss. 12, pp. 762-778
Closed Access | Times Cited: 112
Thimoteus Speer, Stefanie Dimmeler, Stefan Schunk, et al.
Nature Reviews Nephrology (2022) Vol. 18, Iss. 12, pp. 762-778
Closed Access | Times Cited: 112
Coupling Probiotics with 2D CoCuMo‐LDH Nanosheets as a Tumor‐Microenvironment‐Responsive Platform for Precise NIR‐II Photodynamic Therapy
Yu-Sheng Yang, Tingting Hu, Yixin Bian, et al.
Advanced Materials (2023) Vol. 35, Iss. 23
Closed Access | Times Cited: 91
Yu-Sheng Yang, Tingting Hu, Yixin Bian, et al.
Advanced Materials (2023) Vol. 35, Iss. 23
Closed Access | Times Cited: 91
Chronic kidney disease
Paola Romagnani, Rajiv Agarwal, Juliana C.N. Chan, et al.
Nature Reviews Disease Primers (2025) Vol. 11, Iss. 1
Closed Access | Times Cited: 3
Paola Romagnani, Rajiv Agarwal, Juliana C.N. Chan, et al.
Nature Reviews Disease Primers (2025) Vol. 11, Iss. 1
Closed Access | Times Cited: 3
Specific alterations in gut microbiota in patients with chronic kidney disease: an updated systematic review
Jin Zhao, Xiaoxuan Ning, Baojian Liu, et al.
Renal Failure (2021) Vol. 43, Iss. 1, pp. 102-112
Open Access | Times Cited: 90
Jin Zhao, Xiaoxuan Ning, Baojian Liu, et al.
Renal Failure (2021) Vol. 43, Iss. 1, pp. 102-112
Open Access | Times Cited: 90
Indoxyl sulfate induces intestinal barrier injury through IRF1-DRP1 axis-mediated mitophagy impairment
Yinghui Huang, Jie Zhou, Shaobo Wang, et al.
Theranostics (2020) Vol. 10, Iss. 16, pp. 7384-7400
Open Access | Times Cited: 88
Yinghui Huang, Jie Zhou, Shaobo Wang, et al.
Theranostics (2020) Vol. 10, Iss. 16, pp. 7384-7400
Open Access | Times Cited: 88
Probiotics, prebiotics, and synbiotics for the improvement of metabolic profiles in patients with chronic kidney disease: A systematic review and meta-analysis of randomized controlled trials
Hui Juan Zheng, Jing Guo, Qiuhong Wang, et al.
Critical Reviews in Food Science and Nutrition (2020) Vol. 61, Iss. 4, pp. 577-598
Closed Access | Times Cited: 86
Hui Juan Zheng, Jing Guo, Qiuhong Wang, et al.
Critical Reviews in Food Science and Nutrition (2020) Vol. 61, Iss. 4, pp. 577-598
Closed Access | Times Cited: 86
A Comparative Study of the Gut Microbiota Associated With Immunoglobulin a Nephropathy and Membranous Nephropathy
Ruijuan Dong, Ming Bai, Jin Zhao, et al.
Frontiers in Cellular and Infection Microbiology (2020) Vol. 10
Open Access | Times Cited: 70
Ruijuan Dong, Ming Bai, Jin Zhao, et al.
Frontiers in Cellular and Infection Microbiology (2020) Vol. 10
Open Access | Times Cited: 70
Uraemic solutes as therapeutic targets in CKD-associated cardiovascular disease
Jonathan D. Ravid, Mohamed Hassan Kamel, Vipul C. Chitalia
Nature Reviews Nephrology (2021) Vol. 17, Iss. 6, pp. 402-416
Closed Access | Times Cited: 70
Jonathan D. Ravid, Mohamed Hassan Kamel, Vipul C. Chitalia
Nature Reviews Nephrology (2021) Vol. 17, Iss. 6, pp. 402-416
Closed Access | Times Cited: 70
Gut bacterial extracellular vesicles: important players in regulating intestinal microenvironment
Xiao Liang, Nini Dai, Kangliang Sheng, et al.
Gut Microbes (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 60
Xiao Liang, Nini Dai, Kangliang Sheng, et al.
Gut Microbes (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 60
Inulin-type fructans change the gut microbiota and prevent the development of diabetic nephropathy
Liman Luo, Jinlan Luo, Yueting Cai, et al.
Pharmacological Research (2022) Vol. 183, pp. 106367-106367
Closed Access | Times Cited: 53
Liman Luo, Jinlan Luo, Yueting Cai, et al.
Pharmacological Research (2022) Vol. 183, pp. 106367-106367
Closed Access | Times Cited: 53
Microbiome in Chronic Kidney Disease (CKD): An Omics Perspective
Sonnal Lohia, Antonia Vlahou, Jérôme Zoidakis
Toxins (2022) Vol. 14, Iss. 3, pp. 176-176
Open Access | Times Cited: 44
Sonnal Lohia, Antonia Vlahou, Jérôme Zoidakis
Toxins (2022) Vol. 14, Iss. 3, pp. 176-176
Open Access | Times Cited: 44
Gut microbiome studies in CKD: opportunities, pitfalls and therapeutic potential
Hubert Krukowski, Sophie Valkenburg, Avra-Melina Madella, et al.
Nature Reviews Nephrology (2022) Vol. 19, Iss. 2, pp. 87-101
Closed Access | Times Cited: 44
Hubert Krukowski, Sophie Valkenburg, Avra-Melina Madella, et al.
Nature Reviews Nephrology (2022) Vol. 19, Iss. 2, pp. 87-101
Closed Access | Times Cited: 44
Homeostasis in the Gut Microbiota in Chronic Kidney Disease
Shruti Bhargava, Erik Merckelbach, Heidi Noels, et al.
Toxins (2022) Vol. 14, Iss. 10, pp. 648-648
Open Access | Times Cited: 42
Shruti Bhargava, Erik Merckelbach, Heidi Noels, et al.
Toxins (2022) Vol. 14, Iss. 10, pp. 648-648
Open Access | Times Cited: 42
Inflammation and gut dysbiosis as drivers of CKD–MBD
Pieter Evenepoel, Peter Stenvinkel, Catherine M. Shanahan, et al.
Nature Reviews Nephrology (2023) Vol. 19, Iss. 10, pp. 646-657
Closed Access | Times Cited: 23
Pieter Evenepoel, Peter Stenvinkel, Catherine M. Shanahan, et al.
Nature Reviews Nephrology (2023) Vol. 19, Iss. 10, pp. 646-657
Closed Access | Times Cited: 23
Intestinal CXCR6+ ILC3s migrate to the kidney and exacerbate renal fibrosis via IL-23 receptor signaling enhanced by PD-1 expression
Zhou Liang, Ziwen Tang, Changjian Zhu, et al.
Immunity (2024) Vol. 57, Iss. 6, pp. 1306-1323.e8
Open Access | Times Cited: 13
Zhou Liang, Ziwen Tang, Changjian Zhu, et al.
Immunity (2024) Vol. 57, Iss. 6, pp. 1306-1323.e8
Open Access | Times Cited: 13
Causal relationship between gut microbiota and diabetic nephropathy: a two-sample Mendelian randomization study
Shuxiang Yan, Hua Wang, Baiyu Feng, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 10
Shuxiang Yan, Hua Wang, Baiyu Feng, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 10
Targeting Lactobacillus johnsonii to reverse chronic kidney disease
Hua Miao, Fei Liu, Yanni Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 9
Hua Miao, Fei Liu, Yanni Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 9
The gut-liver-kidney axis: Novel regulator of fatty liver associated chronic kidney disease
Desh Raj, Bhawna Tomar, Amit Lahiri, et al.
Pharmacological Research (2019) Vol. 152, pp. 104617-104617
Closed Access | Times Cited: 74
Desh Raj, Bhawna Tomar, Amit Lahiri, et al.
Pharmacological Research (2019) Vol. 152, pp. 104617-104617
Closed Access | Times Cited: 74
